bioept (BIOC)表示,它允许Plus (PSTV)在其临床试验和商业中使用CNSide测试,等待监管部门的批准。Plus Therapeutics (PSTV)的股票在反...查看全文
不入流资讯2023-09-08 20:23
$Plus Therapeutics(PSTV)$ Plus Therapeutics jumps 23% premarket after obtaining a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy查看全文
牛股小红书2022-04-06 13:10
$Plus Therapeutics(PSTV)$ 表示,已扩大与Dassault Systèmes(OTCPK:DASTY)旗下公司Medidata的合作伙伴关系,以加快Rhenium-186纳米脂质体治疗复发性胶质母细胞瘤的2期临床试验的注册速度,降低临床试验成本。
该合作关系将使用Medidata的合成控制臂平台,该平台以美国食品和药物管理局认可...查看全文
薛定锷之猫2021-11-23 09:49
$Plus Therapeutics(PSTV)$ 所谓的放射性纳米疗法治复发性GBM,大概率失败?终于明白当初TOCA为啥也是找晚期复发性GBM下手了。市值2千万,真正的仙股啊。查看全文
$Plus Therapeutics(PSTV)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-042421 Act: 34 Size: 655 KB 网页链接
$Plus Therapeutics(PSTV)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042363 Act: 34 Size: 5 MB 网页链接
$Plus Therapeutics(PSTV)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-23-206816 Act: 33 Size: 452 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-035267 Size: 4 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-23-145665 Act: 34 Size: 151 KB 网页链接
$Plus Therapeutics(PSTV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027213 Size: 4 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 3.03, 5.03, 5.07, 8.01, and 9.01 Accession Number: 0001193125-23-127227 Act: 34 Size: 187 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0000950170-23-013745 Act: 34 Size: 699 KB 网页链接
$Plus Therapeutics(PSTV)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-013672 Act: 34 Size: 609 KB 网页链接
$Plus Therapeutics(PSTV)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-013671 Act: 34 Size: 5 MB 网页链接